State of Alaska Department of Revenue increased its holdings in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 2.8% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 42,232 shares of the financial services provider's stock after purchasing an additional 1,145 shares during the quarter. State of Alaska Department of Revenue's holdings in CME Group were worth $11,203,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. CWA Asset Management Group LLC lifted its stake in CME Group by 31.2% during the first quarter. CWA Asset Management Group LLC now owns 1,147 shares of the financial services provider's stock worth $304,000 after purchasing an additional 273 shares in the last quarter. PUREfi Wealth LLC purchased a new stake in shares of CME Group in the 1st quarter valued at $211,000. Demars Financial Group LLC raised its holdings in shares of CME Group by 15.8% in the 1st quarter. Demars Financial Group LLC now owns 610,756 shares of the financial services provider's stock valued at $162,027,000 after buying an additional 83,543 shares during the period. Chicago Capital LLC lifted its stake in CME Group by 111.2% during the 1st quarter. Chicago Capital LLC now owns 3,006 shares of the financial services provider's stock worth $797,000 after acquiring an additional 1,583 shares in the last quarter. Finally, Inscription Capital LLC purchased a new position in CME Group during the 1st quarter valued at about $590,000. 87.75% of the stock is currently owned by hedge funds and other institutional investors.
CME Group Price Performance
CME stock opened at $272.10 on Thursday. The stock has a market cap of $98.05 billion, a price-to-earnings ratio of 27.37, a PEG ratio of 3.66 and a beta of 0.45. CME Group Inc. has a fifty-two week low of $192.11 and a fifty-two week high of $290.79. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. The business has a 50 day moving average price of $273.65 and a 200 day moving average price of $254.94.
CME Group (NASDAQ:CME - Get Free Report) last issued its quarterly earnings data on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share for the quarter, topping the consensus estimate of $2.61 by $0.19. The business had revenue of $1.64 billion during the quarter, compared to the consensus estimate of $1.56 billion. CME Group had a net margin of 57.71% and a return on equity of 14.03%. The company's revenue was up 10.4% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $2.50 EPS. Equities research analysts anticipate that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.
CME Group Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Wednesday, June 25th. Investors of record on Monday, June 9th will be given a $1.25 dividend. The ex-dividend date of this dividend is Monday, June 9th. This represents a $5.00 dividend on an annualized basis and a yield of 1.84%. CME Group's dividend payout ratio (DPR) is presently 50.30%.
Analyst Upgrades and Downgrades
A number of analysts have issued reports on CME shares. Keefe, Bruyette & Woods boosted their price target on shares of CME Group from $265.00 to $273.00 and gave the stock a "market perform" rating in a research note on Thursday, April 24th. UBS Group upped their target price on shares of CME Group from $290.00 to $305.00 and gave the stock a "buy" rating in a research note on Friday, April 25th. Bank of America increased their target price on shares of CME Group from $200.00 to $219.00 and gave the stock an "underperform" rating in a report on Wednesday, April 2nd. JPMorgan Chase & Co. decreased their price target on shares of CME Group from $223.00 to $211.00 and set an "underweight" rating for the company in a research report on Thursday, April 24th. Finally, Raymond James Financial raised CME Group from a "market perform" rating to an "outperform" rating and set a $287.00 price objective on the stock in a research report on Monday, March 10th. Three investment analysts have rated the stock with a sell rating, eight have given a hold rating and five have issued a buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus price target of $258.20.
View Our Latest Stock Report on CME Group
Insider Buying and Selling at CME Group
In other CME Group news, Director Larry G. Gerdes sold 2,000 shares of CME Group stock in a transaction on Thursday, April 24th. The shares were sold at an average price of $264.10, for a total value of $528,200.00. Following the transaction, the director now directly owns 38,651 shares in the company, valued at approximately $10,207,729.10. The trade was a 4.92% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Derek Sammann sold 4,650 shares of the company's stock in a transaction dated Monday, May 5th. The shares were sold at an average price of $280.61, for a total transaction of $1,304,836.50. Following the completion of the sale, the insider now directly owns 8,336 shares of the company's stock, valued at $2,339,164.96. The trade was a 35.81% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 13,400 shares of company stock worth $3,680,610 over the last 90 days. Corporate insiders own 0.30% of the company's stock.
CME Group Profile
(
Free Report)
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider CME Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.
While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.